Vertex Pharmaceuticals (VRTX) Return on Equity [ROE] (2010 - 2026)
Vertex Pharmaceuticals (VRTX) reported Return on Equity [ROE] of 22.24% for Q2 2026, up 0.64 percentage points from 21.61% a year earlier but down 0.57 percentage points from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Return on Equity [ROE] (2010 - 2026) Analysis & Trends
For FY2025, Vertex Pharmaceuticals posted Return on Equity [ROE] of 22.54%, up 25.69 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of -14.17 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -3.15% in FY2024 (-26.14 pp), 22.99% in FY2023 (-4.68 pp), 27.67% in FY2022 (+2.74 pp) and 24.93% in FY2021 (-11.78 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -6.01% in Q1 2025 and a high of 27.97% in Q2 2022.
- Year over year, Return on Equity [ROE] has now increased in each of the last five quarters, with an average year-over-year change of +3.26 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q1 2026 (a gain of 28.83 percentage points); the low point was Q1 2025 (a drop of 28.26 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 22.82% (Q1 2026), 21.97% (Q4 2025) and 21.31% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 22.24% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 43.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.24% |
| Mar 31, 2026 | 22.82% |
| Dec 31, 2025 | 21.97% |
| Sep 30, 2025 | 21.31% |
| Jun 30, 2025 | 21.61% |
| Mar 31, 2025 | -6.01% |
| Dec 31, 2024 | -3.34% |
| Sep 30, 2024 | -3.16% |
| Jun 30, 2024 | -2.94% |
| Mar 31, 2024 | 22.25% |
| Dec 31, 2023 | 21.23% |
| Sep 30, 2023 | 21.70% |
| Jun 30, 2023 | 22.51% |
| Mar 31, 2023 | 23.00% |
| Dec 31, 2022 | 24.66% |
| Sep 30, 2022 | 26.22% |
| Jun 30, 2022 | 27.97% |
| Mar 31, 2022 | 23.34% |
| Dec 31, 2021 | 23.86% |
| Sep 30, 2021 | 23.24% |
API Access
Vertex Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();